Eugene

[email protected]

LATEST

Aspen Pharmacare To Build $235-Million Sterile Anesthetics Mfg Facility in South Africa
By

By
Aspen Pharmacare, a KwaZulu-Natal, South Africa-headquartered pharmaceutical company, is planning an additional 3.4 billion rand ($235 million) capital investment at its Port Elizabeth, South Africa-based manufacturing site for sterile anesthetics.…

Recipharm Updates on Mfg Ops; Hovione, Quotient Sciences, Jost Chemical, Vetter Expand
By

By
A roundup of the latest expansions and manufacturing updates from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring news from Recipharm, Hovione, Quotient Sciences, Jost Chemical, and…

EMA Expands Contamination Investigation Into Other “Sartan” API Products
By

By
The European Medicines Agency (EMA) is evaluating four more “sartan” active pharmaceutical ingredients (APIs) in hypertension medicines marketed in the EU in addition to its ongoing investigation into impurities found…

Glenmark Pharmaceuticals To Open US Mfg Facility
By

By
Glenmark Pharmaceuticals, a Mumbai, India-headquartered pharmaceutical company, plans to open its first US manufacturing facility in Monroe, North Carolina on October 30, 2018. The Monroe, North Carolina facility is Glenmark’s…

GSK Expands API Production for COPD Inhalers
By

By
GlaxoSmithKline (GSK) has opened a £54-million ($69-million) active pharmaceutical ingredient (API) production building at its site in Montrose, Scotland for respiratory inhalers. APIs for use in GSK’s Ellipta (fluticasone furoate/vilanterol)…

Pfizer Plans Staff Reductions as Part of Reorganization
By

By
As part of Pfizer’s previously announced reorganization, the company plans to reduce its global headcount by around 2% through voluntary retirements and staff reductions this year (2018) and in early…

Novartis, Mylan, Amgen, Samsung Bioepis Launch Biosimilars to AbbVie’s Humira in EU
By

By
Novartis’ Sandoz, Mylan, Amgen, and Samsung Bioepis have launched in the European Union (EU) biosimilars to AbbVie’s Humira (adalimumab), an anti-inflammatory drug and AbbVie’s top-selling drug with global 2017 sales…

Novartis To Acquire Endocyte for $2.1 Billion
By

By
Novartis has agreed to acquire Endocyte, a West Lafayette, Indiana-based biopharmaceutical company developing targeted therapeutics for cancer treatment, for $24 per share, or a total equity value of approximately $2.1…

Merck KGaA Opens $72-Million Packaging Center in Germany
By

By
Merck KGaA has opened a new EUR 63-million ($72-million) packaging center at its headquarters in Darmstadt, Germany. The new 15,000-square-meter facility will be dedicated to packaging and shipping the company’s…

Merck & Co. To Build Biologics Mfg Facility in Ireland
By

By
Merck & Co. plans to build a second biomanufacturing manufacturing facility at its site in Carlow, Ireland that will focus on producing vaccines and biologics. It will also expand warehouse…